全球注射器和針頭市場：市場規模、佔有率和趨勢分析（2026-2032 年）

全球注射器和針頭市場報告（至2032年）

2025年全球注射器和針頭市場規模為49億美元。預計該市場將以1.9%的複合年成長率成長，到2032年達到56億美元。

本報告涵蓋全球注射器和針頭市場，包括醫院、門診診所、疫苗接種、靜脈輸液、藥物給藥和常規護理場所使用的注射器和針頭。

注射器部分包括普通注射器和安全注射器。針頭部分包括普通針頭、安全針頭和鈍頭針頭。

市場成長主要受消費者對較安全產品的需求、疾病發生率上升以及對可靠、低成本注射器材的持續需求所驅動。然而，團購組織和無針器械的興起持續對價格和長期市場擴張構成下行壓力。

市場概覽

全球注射器和針頭市場包括醫療環境中用於藥物給藥、注射、血液採集、配製和臨床操作的大批量耗材產品。

• 市場主要分為兩大類：注射器和針頭。注射器類包括傳統注射器和安全注射器，而針頭類包括傳統針頭、安全針頭和鈍頭針頭。

為減少針刺傷而持續進行的工作不斷影響產品的選擇。監管壓力和職業安全計畫正在加速安全型注射器的普及，並增加用於血管通路的無針連接器的使用。

儘管無針注射系統應用日益廣泛，但傳統注射器和針頭並未被廣泛取代。它們價格低廉、性能可靠、醫護人員熟悉且易於獲取，這些優勢確保了注射器和針頭仍然深深植根於日常醫療護理中。

市場促進因素

過渡到安全產品

對安全產品的追求仍然是注射器和針頭市場最重要的驅動力之一。包括「針刺預防事故法」在內的職業安全法規和法律正在推動安全型產品的普及。

在急診市場，由於檢查、執法以及日益嚴格的醫療採購標準，安全產品的普及程度已相當高。安全注射器和針頭現已廣泛應用於醫院和其他醫療機構，在這些機構中，預防針刺傷是重中之重。

與傳統產品相比，安全產品的售價溢價顯著。平均售價的上漲有助於擴大市場規模，並有助於緩解基礎注射器和針頭類別的部分價格壓力。

替代醫學機構、門診機構、新興市場以及低普及率地區的持續轉型預計將支撐未來的成長。雖然許多已開發國家的醫院市場已經實現了較高的轉型率，但全球轉型尚未完成。

疾病發病率上升

疾病發生率上升是另一個主要因素。隨著世界人口老化和肥胖率上升，糖尿病和癌症等慢性病的發生率預計會增加。

治療這些疾病通常需要使用注射器和針頭進行醫療操作。糖尿病需要頻繁注射和藥物管理，而癌症治療可能涉及反覆的藥物配製、給藥和支持性護理。

肥胖者罹患糖尿病的風險更高，這將進一步增加對注射相關產品的長期需求。隨著慢性病治療數量的增加，預計醫院內外對注射器和針頭的需求都將保持強勁。

這一因素尤其重要，因為注射器和針頭廣泛應用於各種手術和治療途徑。即使醫療設備價格面臨壓力，高使用率也能支撐整體市場穩定。

可靠性和熟悉度

注射器和針頭因其可靠性、便利性和醫護人員的熟悉度而繼續享有盛譽。這些產品價格低廉、隨處可得，且易於在各種醫療環境中使用。

包括氣動式和噴射系統在內的無針注射技術仍在研究中。然而，這些替代技術距離在常規醫療實踐中廣泛取代注射器和針頭還相差甚遠。

在許多臨床工作流程中，注射器和針頭仍然是最實用的選擇。它們在藥物管理、疫苗接種、藥品分發和注射治療中的既定作用，將推動其市場持續成長至2032年。

市場限制

集團採購組織

集團採購組織（GPO）是注射器和針頭市場的主要限制。急診護理市場中超過80%的注射器和針頭都是透過集團採購組織採購的。

這些組織幫助醫院增強議價能力，並降低醫療產品的購買價格。雖然這對醫療服務提供者有利，但卻給平均售價（ASP）帶來了巨大的下行壓力。

此外，集團採購組織（GPO）的存在使得中小型製造商難以進入市場。大批量採購和價格折扣的要求可能會阻礙中小企業競標競標，從而限制它們獲得市場佔有率的能力。

雖然集團採購組織（GPO）有助於降低醫院成本，但它們也可能扼殺創新並降低整體市場價值。這種定價環境可能會在整個預測期內持續抑製成長。

使用無針裝置

為減少針刺傷，安全注射器得到了廣泛應用，同時也促使無針裝置的使用日益增加。無針連接器、密封式靜脈注射系統和輸液幫浦可以減少某些醫院病患工作流程中對傳統針頭注射的需求。

導管和輸液管通常採用魯爾鎖接頭，無需針頭即可透過注射器進行輸液。魯爾鎖系統還允許使用輸液幫浦代替手動注射器進行給藥。

通常來說，預防針刺傷最有效的方法是完全避免使用針頭。因此，人們對無針裝置和無針注射技術的興趣持續成長。

然而，由於注射器和針頭成本低廉且使用方便，預計市場需求將保持穩定。在某些應用領域，無針裝置預計不會限制市場成長，也不會完全取代注射器和針頭。

成熟市場的價格壓力

注射器和針頭市場高度成熟，對價格非常敏感。許多產品已經標準化，廣泛供應，並且通常批量採購。

這造成了競爭激烈的環境，採購部門將價格放在首位。生產規模龐大的大型製造商具有優勢，因為它們能夠以低成本大量供貨。

因此，平均售價（ASP）的漲幅仍然有限。儘管安全性的提高和慢性病患者的需求支撐著市場，但傳統產品類型的價格壓力預計將繼續抑制價值成長。

市場範圍和數據範圍

• 量化範圍：市場規模、市場佔有率、市場預測、市場成長率、銷售量、平均售價。
• 定性研究範圍：市場促進因素和限制因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
• 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
• 建立市場模型：利用銷售量和平均售價（ASP）分析收入，並輔以競爭佔有率分析和預測假設。
• 目標器械：本報告涵蓋注射器和針頭，包括傳統注射器、安全注射器、傳統針頭、安全針頭和鈍頭針頭。

目標市場及區隔

注射器和針頭市場

• 器械類型：注射器和針頭。

注射器類別包括普通注射器和安全注射器。普通注射器仍廣泛應用於成本要求較高的環境以及不強製或無需使用安全型產品的常規應用。

安全注射器內建安全機制，可降低針刺傷的風險。這些產品更常用於急診和監管嚴格的醫療機構，其平均售價通常高於傳統注射器。

針頭分為普通針頭、安全針頭和鈍頭針頭。普通針頭由於成本低廉且廣泛應用於常規注射和給藥流程中，仍佔有重要的地位。

安全針頭旨在減少針刺傷，常用於職業安全健康要求嚴格的環境。鈍頭針頭用於藥物配製，有助於降低灌裝和轉移過程中使用尖銳器械帶來的風險。

每個細分市場都根據市場規模、市場佔有率、市場預測、市場成長率、銷售量和平均售價進行分析。

這種市場細分有助於製造商、投資者和策略團隊了解向安全措施的轉變、對傳統產品的需求、慢性病趨勢、採購壓力以及無針替代品如何影響全球注射器和針頭市場。

競爭分析

2025年，貝克頓·迪金森公司在整個注射器和針頭市場佔領先地位。該公司在醫院領域的領先地位尤為顯著，該領域貢獻了其一半以上的銷售額。

BD 的生產規模使其能夠在保持豐富產品系列的同時，以低成本提供注射器。在供應量、定價和採購關係對競爭成功至關重要的市場中，這種規模是關鍵因素。

BD的產品線包括SafetyGlide™帶防護罩的皮下注射針、Eclipse™旋轉注射針和Integra™伸縮注射器。這些產品鞏固了公司在安全注射器材領域的地位。

泰爾茂是全球注射器和針頭市場第二大競爭對手。該公司擁有豐富的產品組合，涵蓋傳統注射劑和安全型注射。

主要品牌包括泰爾茂®注射器、SurGuard®安全針頭和泰爾茂皮下注射針系列。這些產品廣泛應用於醫院、門診和免疫接種計畫。

泰爾茂的優勢在於其大規模生產能力、穩定的產品品質以及在亞太地區和其他全球市場的高滲透率。這鞏固了公司在競爭激烈的價格細分市場中的地位。

2025年，B. Braun是第三大競爭對手。近年來，該公司市佔率顯著成長，尤其是在德國、法國和英國等地區。 B. Braun生產用於標準劑量和微劑量應用的兩段式和三段式注射器。

技術和實踐趨勢

安全設計的注射器

安全型注射器持續佔市場。這些產品旨在降低針刺傷的風險，並有助於遵守職業安全標準。

由於其平均售價（ASP）高於傳統注射器，因此有助於維持其市場價值。

安全針

安全針頭在醫院和其他受監管的醫療機構中仍然發揮著至關重要的作用。帶有防護罩、旋轉裝置或可伸縮裝置的產品有助於降低使用後受傷的風險。

在法律法規和檢查制度加強，安全措施轉向速度加快的地區，其實施情況最為先進。

無針頭連接器

無針連接器在血管通路的應用日益廣泛。這些系統允許透過魯爾鎖連接進行藥物輸注，而無需使用傳統針頭。

雖然使用注射器可能會減少對特定針頭應用的需求，但並不能完全消除對注射器的需求。

封閉式靜脈注射平台

封閉式靜脈注射平台是降低針刺傷風險、提高給藥安全性的更廣泛努力的一部分。

這些系統可以取代醫院環境中一些需要使用手動針頭的流程。

幫浦輔助給藥

在條件允許的情況下，手動注射器給藥正逐步被輸液幫浦給藥所取代。這減少了某些靜脈輸液流程中對注射器的依賴。

然而，注射器對於許多準備、注射和給藥任務仍然至關重要。

無針注射技術的研究

包括氣體驅動和噴射系統在內的無針注射技術仍在研究中。這些技術有望在某些領域減少針頭的使用。

然而，由於傳統注射器和針頭在成本、工作流程、可靠性和熟悉度方面具有優勢，因此它們並沒有被廣泛取代。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

這份報告的意義

• 目前全球注射器和針頭市場的規模有多大？預計到 2032 年將成長多少？
• 在預測期內，注射器和針頭市場將如何發展？
• 銷售量、平均售價和市場規模如何隨時間變化？
• 轉向安全措施在促進市場規模成長方面發揮著怎樣的作用？
• 預防事故的相關法規如何影響產品的廣泛應用？
• 糖尿病和癌症等疾病發生率的上升對需求產生了怎樣的影響？
• 為什麼美國政府採購組織（GPO）會對注射器和針頭的價格施加如此大的壓力？
• 無針連接器、幫浦和封閉式靜脈輸液系統將如何影響未來的需求？
• 哪些公司在全球注射器和針頭市場處於領先地位？
• BD、Terumo 和 B. Braun 在傳統注射器、安全注射器、傳統針頭、安全針頭和鈍頭針頭的市場中處於什麼位置？

iData Research 的「全球注射器和針頭市場報告」透過設備層級分析、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。該報告可用於評估全球注射器和針頭市場的需求、比較競爭對手、了解向安全產品的過渡以及製定產業計畫。

目錄

調查方法

• 步驟 1：專案啟動與團隊組建
• 步驟 2：準備資料系統並進行二次調查。
• 步驟 3：設計和準備訪談和調查問卷。
• 步驟 4：進行初步調查
• 步驟 5：調查與分析：建立基準估計值
• 步驟 6：市場預測與分析
• 步驟 7：辨識策略機遇
• 步驟 8：最終審核和市場推廣
• 步驟 9：客戶回饋與市場監測

全球關稅的影響

注射器和針頭市場

• 摘要整理
  • 全球注射器和針頭市場概覽
  • 競爭分析
  • 目標市場
  • 目標區域
• 介紹
• 市場概覽
  • 按細分市場
  • 按地區
• 市場分析與預測
  • 注射器市場
  • 針頭市場
• 促進因素和抑制因素
• 競爭性市佔率分析

簡稱

Global Syringe and Needle Market Report to 2032

The global syringe and needle market was valued at $4.9 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 1.9%, reaching $5.6 billion by 2032.

This report covers the global syringe and needle market, including syringes and needles used across hospital, outpatient, vaccination, infusion, medication delivery, and routine care settings.

The syringe segment includes conventional and safety syringes. The needle segment includes conventional needles, safety needles, and blunt fill needles.

Market growth is supported by conversion to safety products, rising disease incidence, and the continued need for reliable low-cost injection devices. However, group purchasing organizations and the use of needleless devices continue to place downward pressure on pricing and long-term market expansion.

Market Overview

The global syringe and needle market includes high-volume consumable products used for medication delivery, injections, blood draws, preparation, and clinical procedures across healthcare settings.

• The market is divided into two main segments: syringes and needles. The syringe segment includes conventional syringes and safety syringes, while the needle segment includes conventional needles, safety needles, and blunt fill needles.

Ongoing efforts to reduce needlestick injuries continue to shape product selection. Regulatory pressure and occupational safety programs have accelerated adoption of safety-engineered syringes and increased the use of needleless connectors for vascular access.

Despite the growth of needleless systems, broad displacement of conventional syringes and needles has not occurred. Their low unit cost, reliability, clinician familiarity, and broad availability ensure that syringes and needles remain deeply embedded in routine care.

Market Drivers

Conversion to Safety Products

Conversion to safety products remains one of the most important drivers of the syringe and needle market. Occupational safety regulations and legislation, including the Needlestick Safety and Prevention Act, have supported widespread adoption of safety-engineered products.

The acute care market has achieved a high degree of safety conversion due to inspection, enforcement, and stronger institutional purchasing standards. Safety syringes and safety needles are now widely used in hospitals and other settings where needlestick injury prevention is a major priority.

Safety products carry a significant price premium over conventional products. This higher ASP has increased the value of the market and helped offset pricing pressure in basic syringe and needle categories.

Ongoing conversion in alternate care sites, outpatient settings, emerging markets, and lower-penetration regions is expected to support future growth. While many developed hospital markets are already highly converted, the global transition is not fully complete.

Increasing Disease Incidence

Increasing disease incidence is another major driver. The incidence of chronic diseases such as diabetes and cancer is expected to rise as the global population ages and obesity rates increase.

These diseases often require medical treatments that rely on syringes and needles. Diabetes can involve frequent injections and medication management, while cancer care may involve repeated medication preparation, administration, and supportive care.

The obese population has a higher risk of developing diabetes, creating additional long-term demand for injection-related products. As chronic disease treatment volumes increase, demand for syringes and needles is expected to remain steady across both hospital and non-hospital care settings.

This driver is especially important because syringes and needles are used across many procedures and treatment pathways. Even where device pricing is under pressure, high utilization volumes support overall market stability.

Reliability and Familiarity

Syringes and needles continue to benefit from reliability, simplicity, and clinician familiarity. These products are inexpensive, widely available, and easy to use in a broad range of care environments.

Needle-free injection technologies, including gas-powered and jet-based systems, continue to be researched. However, these alternatives have not broadly replaced syringes and needles in routine care.

In many clinical workflows, syringes and needles remain the most practical option. Their established role in medication delivery, vaccination, preparation, and injection-based care supports continued growth through 2032.

Market Limiters

Group Purchasing Organizations

Group purchasing organizations are a major limiter of the syringe and needle market. More than 80% of syringes and needles in the acute care market are purchased through GPOs.

These organizations increase the bargaining power of hospitals and help reduce the price paid for medical products. While this benefits healthcare providers, it places strong downward pressure on ASPs.

GPOs also make it difficult for smaller manufacturers to enter the market. High-volume requirements and price discounts can prevent smaller companies from bidding on contracts, limiting their ability to gain share.

Although GPOs help hospitals reduce costs, they can discourage innovation and decrease total market value. This pricing environment will continue to limit growth over the forecast period.

Use of Needleless Devices

The drive to reduce needlestick injuries has supported safety syringes, but it has also increased the use of needleless devices. Needleless connectors, closed IV delivery systems, and pumps can reduce the need for traditional needle-based delivery in certain inpatient workflows.

Catheters and tubing often include Luer-lock connectors, allowing infusion through syringes without needles. Luer-lock systems can also support the use of pumps instead of manual syringe delivery.

In general, preventing needlestick injuries is best achieved by eliminating the use of needles altogether. This has created continued interest in needleless devices and needle-free injection technologies.

However, the low cost and ease of use of syringes and needles are expected to preserve demand. Needleless devices will limit growth in selected applications, but they are not expected to fully displace syringes and needles.

Pricing Pressure in a Mature Market

The syringe and needle market is highly mature and price-sensitive. Many products are standardized, widely available, and purchased in large volumes.

This creates a competitive environment where procurement teams focus heavily on price. Large manufacturers with high production scale have an advantage because they can supply large volumes at lower cost.

As a result, ASP growth remains limited. Even though safety conversion and chronic disease demand support the market, pricing pressure in conventional product categories will continue to constrain value growth.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by competitive share analysis and forecast assumptions.
• Device scope: The report covers syringes and needles, including conventional syringes, safety syringes, conventional needles, safety needles, and blunt fill needles.

Markets Covered and Segmentation

Syringe and Needle Market

• Device type: Syringes and needles.

The syringe segment includes conventional and safety syringes. Conventional syringes remain widely used in cost-sensitive settings and routine applications where safety-engineered products are not mandated or required.

Safety syringes include built-in safety mechanisms intended to reduce needlestick injury risk. These products are more commonly used in acute care and regulated healthcare settings and typically command higher ASPs than conventional syringes.

The needle segment includes conventional needles, safety needles, and blunt fill needles. Conventional needles remain important because of their low cost and broad use across routine injection and preparation workflows.

Safety needles are designed to reduce needlestick injuries and are commonly used in settings with strong occupational safety requirements. Blunt fill needles are used in medication preparation and help reduce sharp-related risk during filling and transfer workflows.

Each segment is analyzed by market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.

This segmentation helps manufacturers, investors, and strategy teams understand how safety conversion, conventional product demand, chronic disease trends, procurement pressure, and needleless alternatives are shaping the global syringe and needle market.

Competitive Analysis

In 2025, Becton Dickinson led the total syringe and needle market. The company's leadership was strongest in the hospital segment, where it generated more than half of its sales.

BD's production scale allows the company to offer syringes at lower costs while maintaining a broad product portfolio. This scale is important in a market where high-volume supply, pricing, and procurement relationships are central to competitive success.

BD's product range includes SafetyGlide(TM) shielding hypodermic needles, Eclipse(TM) pivoting injection needles, and Integra(TM) retractable syringes. These products support the company's presence in safety-engineered injection devices.

Terumo was the second-leading competitor in the global syringe and needle market. The company is supported by a broad portfolio of conventional and safety-engineered injection products.

Key brands include Terumo(R) Syringes, SurGuard(R) safety needles, and Terumo's hypodermic needle lines. These products are widely used across hospitals, outpatient care, and vaccination programs.

Terumo's strength lies in high-volume manufacturing, consistent product quality, and strong penetration in Asia-Pacific and other global markets. This reinforces its position in a largely price-driven segment.

B. Braun was the third-leading competitor in 2025. The company has gained significant market share in recent years, especially in regions such as Germany, France, and the United Kingdom. B. Braun manufactures standard and fine-dose two-part and three-part syringes.

Technology and Practice Trends

Safety-Engineered Syringes

Safety-engineered syringes continue to shape market value. These products are designed to reduce needlestick injury risk and support compliance with occupational safety standards.

Their higher ASPs help support market value compared with conventional syringes.

Safety Needles

Safety needles remain important in hospitals and other regulated healthcare settings. Products with shielding, pivoting, or retractable mechanisms help reduce injury risk after use.

Adoption is strongest where legislation and inspection have accelerated safety conversion.

Needleless Connectors

Needleless connectors are increasingly used in vascular access. These systems allow medication administration through Luer-lock connections without a traditional needle.

Their use limits demand for certain needle applications but does not eliminate the need for syringes.

Closed IV Delivery Platforms

Closed IV delivery platforms are part of the broader effort to reduce needlestick exposure and improve medication delivery safety.

These systems can replace some manual needle-based workflows in inpatient settings.

Pump-Based Delivery

Pumps increasingly replace manual syringe delivery where feasible. This can reduce reliance on syringes in certain infusion workflows.

However, syringes remain essential for many preparation, injection, and administration tasks.

Needle-Free Injection Research

Needle-free injection technologies, including gas-powered and jet-based systems, continue to be researched. These technologies could reduce needle use in selected areas.

However, broad replacement has not occurred due to cost, workflow, reliability, and familiarity advantages of traditional syringes and needles.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global syringe and needle market today, and how much is it expected to grow through 2032?
• How are syringes and needles performing across the forecast period?
• How are unit sales, ASPs, and market values changing over time?
• What role does safety conversion play in supporting market value growth?
• How are needlestick prevention regulations affecting product adoption?
• How is rising disease incidence, including diabetes and cancer, shaping demand?
• Why do GPOs place strong pressure on syringe and needle pricing?
• How are needleless connectors, pumps, and closed IV systems affecting future demand?
• Which companies lead the global syringe and needle market?
• How are BD, Terumo, and B. Braun positioned across conventional syringes, safety syringes, conventional needles, safety needles, and blunt fill needles?

The Global Syringe and Needle Market Report from iData Research answers these questions with device-level analysis, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand safety conversion, and support commercial planning in the global syringe and needle market.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Syringe And Needle Market

• 16.1 Executive Summary
  • 16.1.1 Global Syringe And Needle Market Overview
  • 16.1.2 Competitive Analysis
  • 16.1.3 Markets Included
  • 16.1.4 Regions Included
• 16.2 Introduction
• 16.3 Market Overview
  • 16.3.1 By Segment
  • 16.3.2 By Region
• 16.4 Market Analysis And Forecast
  • 16.4.1 Syringe Market
    • 16.4.1.1 Conventional Syringe Market
    • 16.4.1.2 Safety Syringe Market
  • 16.4.2 Needle Market
    • 16.4.2.1 Conventional Needle Market
    • 16.4.2.2 Safety Needle Market
    • 16.4.2.3 Blunt Fill Needle Market
• 16.5 Drivers And Limiters
  • 16.5.1 Market Drivers
  • 16.5.2 Market Limiters
• 16.6 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 16-1: Syringe and Needle Market, Global, 2025 & 2032
• Chart 16-2: Syringe and Needle Units Sold, Global, 2025
• Chart 16-3: Syringe and Needle Market by Segment, Global, 2022 - 2032
• Chart 16-4: Syringe and Needle Market by Region, Global, 2022 - 2032
• Chart 16-5: Leading Competitors, Syringe and Needle Market, Global, 2025

LIST OF FIGURES

• Figure 16-1: Syringe and Needle Markets Covered
• Figure 16-2: Syringe and Needle Regions Covered, Global (1 of 2)
• Figure 16-3: Syringe and Needle Regions Covered, Global (2 of 2)
• Figure 16-4: Syringe and Needle Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 16-5: Syringe and Needle Market by Region, Global, 2022 - 2032 (US$M)
• Figure 16-6: Syringe Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 16-7: Total Syringe Market, Global, 2022 - 2032
• Figure 16-8: Units Sold by Region, Syringe Market, Global, 2022 - 2032
• Figure 16-9: Average Selling Price by Region, Syringe Market, Global, 2022 - 2032 (US$)
• Figure 16-10: Market Value by Region, Syringe Market, Global, 2022 - 2032 (US$M)
• Figure 16-11: Conventional Syringe Market, Global, 2022 - 2032
• Figure 16-12: Units Sold by Region, Conventional Syringe Market, Global, 2022 - 2032
• Figure 16-13: Average Selling Price by Region, Conventional Syringe Market, Global, 2022 - 2032 (US$)
• Figure 16-14: Market Value by Region, Conventional Syringe Market, Global, 2022 - 2032 (US$M)
• Figure 16-15: Safety Syringe Market, Global, 2022 - 2032
• Figure 16-16: Units Sold by Region, Safety Syringe Market, Global, 2022 - 2032
• Figure 16-17: Average Selling Price by Region, Safety Syringe Market, Global, 2022 - 2032 (US$)
• Figure 16-18: Market Value by Region, Safety Syringe Market, Global, 2022 - 2032 (US$M)
• Figure 16-19: Needle Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 16-20: Total Needle Market, Global, 2022 - 2032
• Figure 16-21: Units Sold by Region, Needle Market, Global, 2022 - 2032
• Figure 16-22: Average Selling Price by Region, Needle Market, Global, 2022 - 2032 (US$)
• Figure 16-23: Market Value by Region, Needle Market, Global, 2022 - 2032 (US$M)
• Figure 16-24: Conventional Needle Market, Global, 2022 - 2032
• Figure 16-25: Units Sold by Region, Conventional Needle Market, Global, 2022 - 2032
• Figure 16-26: Average Selling Price by Region, Conventional Needle Market, Global, 2022 - 2032 (US$)
• Figure 16-27: Market Value by Region, Conventional Needle Market, Global, 2022 - 2032 (US$M)
• Figure 16-28: Safety Needle Market, Global, 2022 - 2032
• Figure 16-29: Units Sold by Region, Safety Needle Market, Global, 2022 - 2032
• Figure 16-30: Average Selling Price by Region, Safety Needle Market, Global, 2022 - 2032 (US$)
• Figure 16-31: Market Value by Region, Safety Needle Market, Global, 2022 - 2032 (US$M)
• Figure 16-32: Blunt Fill Needle Market, Global, 2022 - 2032
• Figure 16-33: Units Sold by Region, Blunt Fill Needle Market, Global, 2022 - 2032
• Figure 16-34: Average Selling Price by Region, Blunt Fill Needle Market, Global, 2022 - 2032 (US$)
• Figure 16-35: Market Value by Region, Blunt Fill Needle Market, Global, 2022 - 2032 (US$M)
• Figure 16-36: Leading Competitors, Syringe and Needle Market, Global, 2025